Treatment goals in ANCA-associated vasculitis: defining success in a new era
F Alberici, M Tedesco, T Popov… - Frontiers in …, 2024 - frontiersin.org
Health-related quality of life is a key contributor to overall well-being, and this is becoming
an increasingly prominent factor when making therapeutic choices in the management of …
an increasingly prominent factor when making therapeutic choices in the management of …
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
M Macía, M Díaz-Encarnación… - Expert Review of …, 2024 - Taylor & Francis
Background Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) are rare
autoimmune diseases characterized by inflammation of blood vessels. This study aimed to …
autoimmune diseases characterized by inflammation of blood vessels. This study aimed to …